X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35088) 35088
Publication (2100) 2100
Newspaper Article (283) 283
Book Review (245) 245
Magazine Article (198) 198
Newsletter (164) 164
Book Chapter (144) 144
Book / eBook (77) 77
Conference Proceeding (38) 38
Dissertation (24) 24
Trade Publication Article (15) 15
Web Resource (13) 13
Streaming Video (6) 6
Reference (5) 5
Data Set (2) 2
Journal / eJournal (1) 1
Microfilm (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26243) 26243
male (18413) 18413
female (15253) 15253
middle aged (11369) 11369
adult (9920) 9920
aged (8545) 8545
index medicus (7630) 7630
animals (7382) 7382
ulcers (5689) 5689
gastric mucosa - pathology (4484) 4484
stomach ulcer - pathology (4132) 4132
rats (3859) 3859
gastroenterology & hepatology (3800) 3800
surgery (3214) 3214
biopsy (3126) 3126
adolescent (2823) 2823
aged, 80 and over (2793) 2793
helicobacter pylori (2665) 2665
pathology (2645) 2645
diagnosis, differential (2615) 2615
treatment outcome (2523) 2523
dermatology (2312) 2312
wound healing (2268) 2268
ulcer - pathology (2217) 2217
skin ulcer - pathology (2055) 2055
risk factors (2023) 2023
disease (1906) 1906
chronic disease (1903) 1903
diagnosis (1833) 1833
ulcer (1800) 1800
infection (1798) 1798
time factors (1776) 1776
care and treatment (1755) 1755
duodenal ulcer - pathology (1732) 1732
follow-up studies (1616) 1616
gastric mucosa - drug effects (1603) 1603
child (1562) 1562
research (1561) 1561
stomach ulcer - chemically induced (1549) 1549
retrospective studies (1537) 1537
skin - pathology (1530) 1530
stomach neoplasms - pathology (1516) 1516
anti-ulcer agents - therapeutic use (1505) 1505
pharmacology & pharmacy (1444) 1444
peptic ulcer - pathology (1432) 1432
mice (1424) 1424
stomach - pathology (1402) 1402
health aspects (1380) 1380
gastritis - pathology (1315) 1315
research article (1314) 1314
skin (1298) 1298
helicobacter infections - pathology (1292) 1292
recurrence (1270) 1270
infections (1261) 1261
inflammation (1253) 1253
cancer (1250) 1250
prevalence (1250) 1250
endoscopy (1239) 1239
gastroscopy (1234) 1234
disease models, animal (1218) 1218
skin ulcer - etiology (1204) 1204
prospective studies (1190) 1190
patients (1185) 1185
rats, wistar (1167) 1167
medicine, general & internal (1162) 1162
medicine (1147) 1147
analysis (1124) 1124
necrosis (1124) 1124
intestinal mucosa - pathology (1117) 1117
stomach ulcer - etiology (1093) 1093
stomach (1091) 1091
oncology (1090) 1090
stomach ulcer - drug therapy (1049) 1049
peptic ulcer (1033) 1033
helicobacter infections - complications (1028) 1028
gastric mucosa - metabolism (1014) 1014
helicobacter pylori - isolation & purification (1008) 1008
management (1001) 1001
prognosis (979) 979
leg ulcer - pathology (976) 976
gastritis (958) 958
helicobacter infections - drug therapy (955) 955
helicobacter infections - microbiology (949) 949
young adult (940) 940
immunohistochemistry (932) 932
gastritis - microbiology (927) 927
diabetes (922) 922
rats, sprague-dawley (915) 915
therapy (909) 909
expression (896) 896
microbiology (892) 892
ulcer - etiology (890) 890
medicine, research & experimental (887) 887
stomach ulcer - complications (883) 883
immunology (852) 852
medicine & public health (843) 843
anti-bacterial agents - therapeutic use (837) 837
stomach ulcer - prevention & control (831) 831
radiography (825) 825
duodenal-ulcer (816) 816
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (60) 60
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29827) 29827
Russian (1467) 1467
French (1176) 1176
German (1060) 1060
Japanese (621) 621
Spanish (520) 520
Italian (345) 345
Chinese (210) 210
Polish (110) 110
Portuguese (82) 82
Romanian (70) 70
Ukrainian (66) 66
Dutch (62) 62
Danish (57) 57
Hungarian (56) 56
Bulgarian (50) 50
Czech (46) 46
Korean (40) 40
Croatian (33) 33
Swedish (24) 24
Turkish (23) 23
Norwegian (22) 22
Serbian (12) 12
Finnish (11) 11
Slovak (10) 10
Hebrew (9) 9
Lithuanian (3) 3
Slovenian (3) 3
Arabic (2) 2
Greek (2) 2
Afrikaans (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastrointestinal Endoscopy, ISSN 0016-5107, 2013, Volume 78, Issue 2, pp. 216 - 224
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e35072
H. pylori drug-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. For some bacterial species it has been... 
RESPONSES | POLYUNSATURATED FATTY-ACIDS | INFECTION | MONOGLYCERIDES | STRAIN | BIOLOGY | Gastritis - drug therapy | Gastric Mucosa - microbiology | Mice, Inbred C57BL | Helicobacter pylori - ultrastructure | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Docosahexaenoic Acids - administration & dosage | Helicobacter Infections - pathology | Docosahexaenoic Acids - pharmacology | Animals | Gastritis - pathology | Helicobacter Infections - drug therapy | Gastritis - microbiology | Anti-Bacterial Agents - pharmacology | Mice | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Unsaturated fatty acids | Helicobacter pylori | Growth | Analysis | Helicobacter infections | Health aspects | Omega-3 fatty acids | Antiulcer drugs | Therapy | Stomach | Disease | Fish oils | Mucosa | Gastric mucosa | Infections | Drug resistance | Docosahexaenoic acid | Fatty acids | Stomach cancer | Inflammatory diseases | Medicine | Studies | Pathology | Immunology | Antibiotics | Ulcers | Biomarkers | Bacteria | In vivo methods and tests | Colonization | Helicobacter Infections/drug therapy | Docosahexaenoic Acids/administration & dosage | Anti-Bacterial Agents/administration & dosage | Helicobacter Infections/pathology | Helicobacter Infections/microbiology | Gastritis/drug therapy | Anti-Bacterial Agents/pharmacology | Bacteriology | Helicobacter pylori/drug effects | Helicobacter pylori/ultrastructure | Gastritis/pathology | Life Sciences | Microbiology and Parasitology | Human health and pathology | Gastritis/microbiology | Infectious diseases | Gastric Mucosa/microbiology | Gastric Mucosa/pathology
Journal Article
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2010, Volume 71, Issue 4, pp. 663 - 668
Gastroenterology and Hepatology | GIANT DUODENAL-ULCER | UNITED-STATES | DIAGNOSIS | RISK-FACTORS | GASTRIC OUTLET OBSTRUCTION | GASTROINTESTINAL-TRACT | PYLORIC-STENOSIS | DOUBLE-BLIND | TERM-FOLLOW-UP | BALLOON DILATION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Peptic Ulcer Perforation - chemically induced | Stomach Ulcer - pathology | Duodenal Ulcer - chemically induced | Duodenal Ulcer - diagnosis | Gastric Mucosa - pathology | Helicobacter Infections - complications | Stomach Neoplasms - pathology | Peptic Ulcer Perforation - diagnosis | Helicobacter Infections - pathology | Helicobacter Infections - therapy | Peptic Ulcer Hemorrhage - pathology | Peptic Ulcer Perforation - therapy | Helicobacter pylori | Gastric Outlet Obstruction - diagnosis | Gastric Outlet Obstruction - therapy | Gastric Outlet Obstruction - pathology | Helicobacter Infections - diagnosis | Endoscopy, Digestive System | Duodenal Neoplasms - pathology | Stomach Ulcer - diagnosis | Stomach Ulcer - chemically induced | Diagnosis, Differential | Peptic Ulcer Perforation - pathology | Duodenal Ulcer - pathology | Stomach Neoplasms - diagnosis | Peptic Ulcer Hemorrhage - chemically induced | Stomach Neoplasms - therapy | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Evidence-Based Medicine | Peptic Ulcer Hemorrhage - therapy | Duodenal Ulcer - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Biopsy | Duodenum - pathology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Gastric Outlet Obstruction - chemically induced | Stomach Ulcer - therapy | Peptic Ulcer Hemorrhage - diagnosis | Intestinal Mucosa - pathology | Peptic ulcer | Care and treatment
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 05/2015, Volume 29, Issue 5, pp. 991 - 997
BackgroundProgression from actinic keratosis (AK) to invasive squamous cell carcinoma (iSCC) of the skin is thought to occur after the development of full... 
PROPOSAL | SOLAR KERATOSIS | DISEASE | DERMATOLOGY | Skin Neoplasms - pathology | Epidermis - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Skin Ulcer - pathology | Keratinocytes - pathology | Aged, 80 and over | Female | Aged | Cell Transformation, Neoplastic - pathology | Keratosis, Actinic - pathology
Journal Article
JOURNAL OF NEUROVIROLOGY, ISSN 1355-0284, 02/2016, Volume 22, Issue 1, pp. 22 - 32
We seek an aetiopathogenic model for the spectrum of Parkinson's disease (PD), functional bowel disease, depression and cognitive impairment. The adopted... 
Autoimmunity | Intestinal dysbiosis | CHRONIC INFECTION | Pathogenesis | Helicobacter | INTESTINAL MICROBIOTA | ALZHEIMERS-DISEASE | IDIOPATHIC PARKINSONISM | Parkinson's and overlap diseases | DOPAMINERGIC-NEURONS | BRAIN PATHOLOGY | SUBSTANTIA-NIGRA | NEUROSCIENCES | Aetiology | HUMAN GUT MICROBIOME | Bystander damage | VIROLOGY | HELICOBACTER-PYLORI ERADICATION | GROWTH-FACTOR-ALPHA | Depression - pathology | Humans | Helicobacter pylori - pathogenicity | Killer Cells, Natural - pathology | Peptic Ulcer - epidemiology | CD4-Positive T-Lymphocytes - pathology | Dysbiosis - microbiology | Helicobacter Infections - pathology | Inflammatory Bowel Diseases - epidemiology | Cognition Disorders - microbiology | Peptic Ulcer - microbiology | Inflammatory Bowel Diseases - pathology | Parkinson Disease - epidemiology | Neutrophils - microbiology | Killer Cells, Natural - microbiology | Neutrophils - pathology | Parkinson Disease - pathology | CD4-Positive T-Lymphocytes - microbiology | Depression - epidemiology | Comorbidity | Helicobacter pylori - growth & development | Cognition Disorders - pathology | Gastrointestinal Microbiome | Helicobacter Infections - epidemiology | Depression - microbiology | Inflammation | Peptic Ulcer - pathology | Animals | Parkinson Disease - microbiology | Dysbiosis - epidemiology | Inflammatory Bowel Diseases - microbiology | Dysbiosis - pathology | Cognition Disorders - epidemiology | Helicobacter Infections - microbiology
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2013, Volume 182, Issue 3, pp. 806 - 818
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2016, Volume 22, Issue 25, pp. 5655 - 5667
The incidence of inflammatory bowel diseases(IBD)-Crohn’s disease(CD) and ulcerative colitis(UC)- has been increasing on a global scale, and progressively,... 
side | effects | colitis;Drugrelated | and | bowel | Crohn’s | disease;Ulcerative | adverse | reactions;Inflammatory | Inflammatory bowel disease | Crohn's disease | Extraintestinal manifestations | Malnutrition | Drugrelated side effects and adverse reactions | Ulcerative colitis | RHEUMATOID-ARTHRITIS | LOW-DOSE METHOTREXATE | CROHNS-DISEASE | PNEUMOCYSTIS-CARINII-PNEUMONIA | ULCERATIVE-COLITIS | PYOSTOMATITIS-VEGETANS | Drug-related side effects and adverse reactions | EVIDENCE-BASED CONSENSUS | LYMPHOPROLIFERATIVE DISORDER | OF-THE-LITERATURE | GASTROENTEROLOGY & HEPATOLOGY | RECURRENT APHTHOUS STOMATITIS | Humans | Malnutrition - etiology | Oral Ulcer - etiology | Crohn Disease - complications | Cheilitis - physiopathology | Drug-Related Side Effects and Adverse Reactions | Gingivitis - physiopathology | Cheilitis - etiology | Colitis, Ulcerative - drug therapy | Stomatitis, Aphthous - etiology | Mouth Diseases - physiopathology | Colitis, Ulcerative - complications | Stomatitis - physiopathology | Lip Diseases - physiopathology | Oral Ulcer - physiopathology | Malnutrition - physiopathology | Stomatitis - etiology | Mouth Diseases - etiology | Crohn Disease - drug therapy | Stomatitis, Aphthous - physiopathology | Gingivitis - etiology | Immunosuppressive Agents - adverse effects | Crohn Disease - physiopathology | Lip Diseases - etiology | Colitis, Ulcerative - physiopathology | Topic Highlight | Crohn’s disease
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 405 - 417
We describe a series of Epstein Barr virus (EBV)-positive circumscribed, ulcerative lesions associated with various types of immunosuppression (IS). The study... 
Immunosuppression | Lymphoprolifeative | Epstein Barr virus | Mucocutaneous | SURGERY | CELL LYMPHOPROLIFERATIVE DISORDERS | OPTIMAL PRIMER SELECTION | NON-HODGKINS-LYMPHOMAS | immunosuppression | lymphoproliferative | PERIPHERAL-BLOOD | PATHOLOGY | CD8(+) T-CELLS | LYMPHOCYTE SUBPOPULATIONS | mucocutaneous | CYTOMEGALOVIRUS SEROPOSITIVITY | CHAIN-REACTION ANALYSIS | ELDERLY-PATIENTS | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Recurrence | Humans | Middle Aged | Lymphoproliferative Disorders - chemically induced | Male | Skin Ulcer - immunology | Gastrointestinal Diseases - virology | T-Lymphocytes - virology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | T-Lymphocytes - drug effects | Aged, 80 and over | B-Lymphocytes - virology | Gastrointestinal Diseases - pathology | Skin Diseases, Infectious - virology | Skin Diseases, Infectious - pathology | Mouth Mucosa - immunology | Immune Tolerance | Gastrointestinal Diseases - therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | B-Lymphocytes - immunology | Mouth Mucosa - virology | Remission, Spontaneous | T-Lymphocytes - immunology | Oral Ulcer - pathology | Skin Diseases, Infectious - immunology | Age Factors | Oral Ulcer - immunology | Lymphoproliferative Disorders - immunology | Lymphoproliferative Disorders - therapy | Oral Ulcer - chemically induced | Mouth Mucosa - drug effects | In Situ Hybridization | Epstein-Barr Virus Infections - chemically induced | Polymerase Chain Reaction | Adult | Female | Skin Ulcer - virology | Skin Diseases, Infectious - therapy | Gastrointestinal Diseases - immunology | Skin Ulcer - therapy | Epstein-Barr Virus Infections - immunology | Gene Rearrangement, T-Lymphocyte | Lymphoproliferative Disorders - virology | Skin Diseases, Infectious - chemically induced | Treatment Outcome | Skin Ulcer - chemically induced | Genes, Immunoglobulin | B-Lymphocytes - drug effects | Oral Ulcer - therapy | Skin Ulcer - pathology | Immunosuppressive Agents - adverse effects | Aged | Oral Ulcer - virology | Gastrointestinal Diseases - chemically induced | Muco-cutaneous | Lymphoproliferative
Journal Article